New Jersey Medicaid issued two Newsletters describing a change to reimbursement at actual acquisition cost (AAC) for fee-for-service (FFS) Medicaid claims, a new professional fee applicable to retail and long-term-care pharmacy services, and required claim level identification of drugs purchased at the 340B discount (the “Newsletters”).
Also, in response to recent communications from certain Medicaid managed care plans (MCOs), we have clarified with NJ Medicaid officials that managed care plans have not been directed by Medicaid to reimburse providers at AAC for 340B or otherwise.
 DMAHS Newsletters, Volume 27, Nos. 03 and 04, dated March 2017. The Newsletters can be found at: https://www.njmmis.com/documentDownload.aspx?fileType=076B9D7D-96DC-4C8A-B9CE-BA46F47DDE1F.
Click Here to read entire Legal Alert.
* * * * *
If you have any questions about this alert, please contact your local Garfunkel Wild office.
|About Garfunkel Wild, P.C.|
Garfunkel Wild, P.C. was founded in 1980 with a single purpose in mind: to become a pre-eminent health care law firm attending to the unique business and legal needs of its clients. Since then, the firm has grown to over 70 attorneys devoted to addressing the complex legal, regulatory, business and financial needs of its diverse clients.
If you would like to receive Legal Alert mailings from Garfunkel Wild, P.C. electronically in the future, or if you would like to be removed from the mailing list, please contact us at (516) 393-2200 or eMail us at email@example.com. You may also visit the Firm’s website.
THIS MATERIAL IS INTENDED AS INFORMATIONAL ONLY AND THE CONTENT SHOULD NOT BE CONSTRUED AS LEGAL ADVICE. READERS SHOULD NOT ACT UPON INFORMATION IN THIS MATERIAL WITHOUT FIRST SEEKING PROFESSIONAL ADVICE.